Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic Oncology Group.

• DOI: 10.1200/jco.2013.31.15_suppl.3
• Publication Date: 2020-03-11T19:26:33Z
• Authors: Krishnansu Sujata...; Michael Sill; Harry J. Long; Lois M. Ramondetta; Lisa Michelle Lan...; Ana Oaknin; Thomas J Reid; Mario M. Leitao; Helen E Michael; Bradley J. Monk
• Keywords: Gynecologic oncology; Clinical Oncology

3 The full, final text of this abstract will be available at abstract.asco.org 7:30 AM (EDT) on Sunday, June, 2, 2013, and in the Annual Meeting Proceedings online supplement to June 20, issue Journal Clinical Oncology. Onsite Meeting, printed Sunday edition ASCO Daily News.